After Hours: Esperion shares rally on cholesterol drug study

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 1 October, 2014 by The TZ Newswire Staff

After Hours: Esperion shares rally on cholesterol drug study

Shares of Esperion Therapeutics rally after the drug developer said its treatment significantly lowered bad cholesterol in patients enrolled in a clinical trial.
read more

See also
- Next Article Target date for Box IPO slides again
- Previous Article The Wall Street Journal: DirecTV, NFL extend ‘Sunday Ticket’ package
Editorial Calender

October 2014

M T W T F S S

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30 31

« Sep Nov »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 1 October, 2014 by The TZ Newswire Staff

After Hours: Esperion shares rally on cholesterol drug study

See also

Editorial Calender

Recent Tags